The findings suggest that dietary choices could help manage high blood pressure in older age, a condition linked to greater risks of heart disease, heart attack, and stroke.

Two Weeks, Twice a Day

The study involved 36 adults in their 60s and 70s and compared their responses with 39 younger adults under 30.

Participants drank concentrated beetroot juice twice a day over a two-week period. They also took a placebo version, with nitrate removed, for another two weeks.

Older adults saw a noticeable drop in blood pressure after the nitrate-rich beet juice period, but the same was not true when they consumed the placebo. Younger adults, despite drinking the same juice, did not experience a significant change in blood pressure.

The Microbiome Connection

The researchers highlighted the oral microbiome, the collection of bacteria living in the mouth, as a central factor. In older adults, beet juice led to fewer potentially harmful bacteria such as Prevotella and more beneficial bacteria such as Neisseria.

These bacteria are essential because they help convert dietary nitrate into nitric oxide. Nitric oxide helps blood vessels loosen, which makes circulation smoother and reduces blood pressure. As people age, their natural ability to produce nitric oxide declines, making them more reliant on this bacterial pathway.

While younger adults also experienced microbiome changes, their blood pressure did not fall. Researchers suggest this is because younger people already produce more nitric oxide naturally, so extra dietary nitrate has less impact. In contrast, older adults tend to have higher blood pressure and less nitric oxide, making them more responsive to dietary interventions.

Expert Views

Professor Anni Vanhatalo from the University of Exeter explained that increasing nitrate-rich vegetables in the diet could be a simple, low-cost way to support vascular health in older age. She noted that beets are not the only option—spinach, rocket (arugula), fennel, celery, and kale also provide dietary nitrate.

Co-author Professor Andy Jones added that these results pave the way for larger studies that consider lifestyle factors and differences between men and women in response to dietary nitrate.

Dr. Lee Beniston of the UK’s Biotechnology and Biological Sciences Research Council, which helped fund the work, said the study highlights how nutrition, oral bacteria, and ageing are closely linked.

Other Research on Beets and Blood Pressure

This is not the first time beets have been linked to heart health. Previous meta-analyses found that beetroot juice can reduce systolic blood pressure in adults. The effects, however, vary depending on dose, duration, and individual health conditions.

Some experts also caution that excessive nitrates can be harmful, especially if they form compounds called nitrosamines in the stomach. For most people, however, eating vegetables high in nitrates is safe and beneficial.

Practical Takeaways

For older adults looking to support heart health, small dietary changes may help:

Daily habit: A small shot of beetroot juice once or twice a day may reduce blood pressure in just two weeks.

Alternative vegetables: Spinach, celery, rocket, and kale also provide nitrates.

Oral care: Avoid strong antiseptic mouthwashes, which can wipe out helpful bacteria that aid nitrate conversion.

Heart health basics: Combine a nitrate-rich diet with exercise, reduced salt intake, and good sleep for long-term benefits.

[Source]

The post Beet Juice May Lower Blood Pressure in Older Adults in Just Two Weeks appeared first on Medical Journal Daily.

The new testing system is currently undergoing trials in Cumbria and the North East of England, and health officials plan to extend its availability to the rest of the UK before the end of the year. If successful, it could offer lessons for healthcare systems worldwide, including the United States, where over 37 million adults live with diabetes and millions remain undiagnosed.

How the Test Works

PocDoc’s test is built around the HbA1c marker, widely recognized as the benchmark for identifying and tracking type 2 diabetes. HbA1c measures average blood glucose levels over the past two to three months, offering a reliable picture of long-term sugar control rather than just a single reading. To use the test, patients begin with a simple finger-prick to provide a small blood sample.

The sample is then applied to PocDoc’s patented microfluidic test cartridge, which is designed to capture and process the biomarker. Using the companion smartphone app, the cartridge is scanned, and results are generated in less than 10 minutes, eliminating the need for laboratory analysis.

By shifting screening away from clinics and into homes, pharmacies, and community spaces, the technology reflects a broader trend in digital health—giving individuals greater control and convenience in monitoring chronic conditions such as diabetes.

Why It Matters for Public Health

Type 2 diabetes is one of the most preventable chronic conditions, yet it continues to grow rapidly worldwide. In the UK, around 5.2 million people live with the disease, and another 1.3 million are undiagnosed. Treating diabetes and its complications costs the National Health Service (NHS) about £8.8 billion annually, nearly 10% of its total budget.

In the United States, the challenge is even greater. The Centers for Disease Control and Prevention (CDC) reports that diabetes costs the U.S. healthcare system $327 billion each year, with nearly $1 in every $4 healthcare dollars spent on treating the disease. Alarmingly, 96 million Americans are estimated to have prediabetes, but the majority do not know it.

For both the NHS and U.S. healthcare providers, earlier detection could significantly reduce long-term costs and complications. Lifestyle interventions, such as improved diet, exercise, and weight management, have been shown to reduce the risk of type 2 diabetes by nearly 50% if introduced early.

Professor Julia Newton from Health Innovation Northeast and North Cumbria highlighted this potential: “Type 2 diabetes can often be prevented or even reversed through early detection and lifestyle change. Making tests available at the touch of a button could be a game-changer.”

Implications for U.S. Healthcare

The United States faces unique challenges in managing diabetes. While annual screenings are recommended for high-risk groups, access remains uneven—particularly in rural areas, among uninsured populations, and in communities with limited primary care.

Smartphone-based testing could help bridge these gaps. With more than 85% of U.S. adults owning a smartphone, app-driven diagnostics could reach populations underserved by traditional healthcare. Pharmacies, employer wellness programs, and telehealth providers could integrate rapid HbA1c testing into their services, helping millions access earlier screenings.

That said, scaling such a system in the U.S. would require FDA approval, insurance integration, and careful oversight to ensure accuracy. The FDA has previously flagged risks with some health apps that failed to provide reliable alerts. Ensuring data security and equitable access will also be critical.

Still, experts believe that digital-first models could save billions annually by reducing hospitalizations, dialysis treatments, and cardiovascular emergencies linked to late-diagnosed diabetes.

The Future of At-Home Testing

The diabetes test is not PocDoc’s first foray into digital diagnostics. The company also launched a Healthy Heart Check, an at-home cholesterol and cardiovascular risk screening kit. Its success indicates a broader shift toward self-administered, technology-driven preventive care.

If the diabetes test proves successful in the UK, expansion into other markets could follow. For U.S. patients, this would mean faster access to critical health information and greater control over managing their risk factors.

As healthcare systems worldwide grapple with rising chronic disease costs, tools like the PocDoc test show how technology and preventive medicine can work hand-in-hand. Instead of waiting for symptoms to appear or results to trickle in from distant labs, patients could soon hold answers in the palm of their hand—literally.

[Source]

The post Diabetes Smartphone Test Could Diagnose Condition in Under 10 Minutes appeared first on Medical Journal Daily.

The peer-reviewed paper, published in PAIN, used both careful pain testing and brain imaging to unpack why this works.

What the new study found

Researchers induced sensitization in the nervous system of 30 healthy adults using a standard high-frequency stimulation model, which reliably mimics features of long-term, neuropathic-like pain. Participants then experienced one of three conditions: a 45-minute 360° VR nature session (waterfalls in Oregon), the same footage on a regular 2D screen, or no intervention.

Only the immersive VR condition meaningfully reduced the development and spread of mechanical secondary hyperalgesia (a hallmark of sensitized pain processing), and the benefit persisted through the end of the session. Crucially, relief scaled with “presence”—the stronger the feeling of being in nature, the greater the analgesia.

University summaries note that immersive VR nature was roughly twice as effective as 2D video at reducing pain experience, and that reductions in pain-related sensitivity were still evident at least five minutes after the session. For people who can’t easily access green spaces—like many living with chronic conditions—this matters: VR can deliver a therapeutically rich “dose” of nature on demand.

How it may work in the brain

The researchers also tested brain activity with MRI scans while participants experienced pain from a cold gel. They found that watching nature in VR changed how certain brain regions ‘talked’ to each other. Specifically, it seemed to help the brain’s natural pain-control system kick in, so fewer pain signals spread through the nervous system.

The effect was strongest when people really felt like they were inside the virtual nature scene, which suggests that the sense of presence helps the brain turn down pain more effectively.

The Exeter work builds on a broader line of evidence that nature exposure—virtual or real—tempers pain. Earlier in 2025, a Nature Communications study showed that simply watching well-designed nature videos lowered both reported pain and brain activity tied to pain processing compared with urban or indoor scenes. The authors argued this wasn’t placebo; the brain’s nociceptive (pain-signal) pathways were genuinely less reactive.

VR isn’t a magic bullet, but it is becoming a legitimate tool in multimodal pain management. In 2021, the U.S. FDA authorized the first at-home VR therapeutic for chronic low-back pain—a program grounded in behavioral skills rather than nature content—after randomized trials showed meaningful, durable benefits.

The regulatory milestone signaled that immersive, non-drug approaches can cross the bar for safety and effectiveness. Nature-based VR adds another, potentially complementary, path: it leans on our hard-wired response to natural environments to turn down pain signaling—with minimal side effects.

What this means for people with chronic pain

For clinics, hospitals, and care homes—places where stepping outside isn’t always feasible—curated VR nature sessions could offer accessible, low-risk relief and pair easily with physical therapy, CBT, or medications.

The practical takeaways from the new study are straightforward: aim for immersive, high-quality 360° nature content; run sessions long enough to let presence build (the study used ~45 minutes); and measure outcomes beyond immediate distraction, since benefits persisted.

The PAIN trial simulated chronic-like sensitization in healthy volunteers; it didn’t test people diagnosed with chronic pain, and the sample was small.

We still need large, real-world trials in specific conditions (e.g., neuropathic pain, fibromyalgia), dose-finding work (how often, how long), and comparisons across different natural environments and personalization levels. But taken together with the 2025 neuroimaging results and past VR analgesia research, the case for “virtual nature as therapy” is getting stronger.

[Source]

The post Virtual Reality Nature Scenes Found to Ease Chronic Pain, Study Shows appeared first on Medical Journal Daily.

Researchers analyzed nationally representative data sets from 2017 and 2023 using Rome Foundation criteria, which are the global standard for diagnosing disorders of gut-brain interaction (DGBIs). These disorders include common but often misunderstood conditions like irritable bowel syndrome (IBS) and functional dyspepsia.

Sharp Increases in IBS and Functional Dyspepsia

The study found that disorders of gut-brain interaction became more common after the pandemic. In 2017, about 38% of people were affected, but by 2023, that number had grown to over 42%. Cases of irritable bowel syndrome (IBS) went up by 28%, increasing from 4.7% to 6%. Functional dyspepsia—a condition that causes ongoing discomfort in the upper stomach without a clear cause—rose even more sharply, jumping nearly 44% from 8.3% to 11.9%.

While these conditions are not new, the increase in their prevalence following the COVID-19 pandemic highlights a concerning trend. Researchers say the data provides the first direct, population-level evidence of how the pandemic has affected gut-brain health.

Long COVID Patients Most Affected

The study also found that individuals with long COVID—persistent symptoms lasting weeks or months after the initial infection—were significantly more likely to report gut-brain disorders. These patients also had higher levels of anxiety and depression and reported a lower overall quality of life.

This connection between long COVID and DGBIs supports previous hypotheses about the long-term effects of SARS-CoV-2 on the gut-brain axis. The virus is known to impact both the gastrointestinal system and the central nervous system, and researchers suggest these effects may persist long after the acute infection resolves.

Why the Gut-Brain Axis Matters

Disorders of gut-brain interaction happen when the signals between the digestive system and the brain don’t work properly, leading to ongoing gut symptoms without a clear physical cause. This can lead to chronic symptoms such as pain, bloating, irregular bowel movements, and nausea, without detectable physical abnormalities. These conditions are often linked with psychological factors like stress, anxiety, and depression.

The Rome Foundation criteria used in the study allow for precise diagnosis based on symptom patterns and have helped move these disorders out of the realm of “medically unexplained” and into evidence-based care.

A Call for Updated Care Models

The findings underline the need to adapt healthcare approaches in the post-pandemic era. Experts are calling for integrated treatment strategies that address both the physical and psychological aspects of gut-brain disorders.

“The data reinforces that long COVID is not just about fatigue or respiratory symptoms,” the researchers note. “It has lasting consequences for gastrointestinal and mental health.”

They also stress the importance of further research into how COVID-19 alters gut-brain signaling and why some individuals are more vulnerable to long-term effects.

[Source]

The post Why More People Are Struggling with Gut Issues After COVID appeared first on Medical Journal Daily.

Why Subtypes Matter

Autism is known for its complexity. Despite being highly heritable, with hundreds of genes linked to it, only about 20% of cases reveal a clear genetic cause. Until now, clinical diagnosis relied on broad categories based on social communication challenges and repetitive behaviors. These general classifications miss much of the diversity within the spectrum.

The new study, conducted by researchers at Princeton University and the Simons Foundation, breaks this down. By analyzing data from the SPARK cohort—tracking over 230 traits in children aged 4 to 18—the team used a statistical model to group individuals by shared characteristics and then mapped those to their genetic differences.

The Four Autism Subtypes

1. Social and Behavioral Challenges (37%)
   Children in this group had pronounced social communication difficulties and repetitive behaviors, along with conditions such as ADHD, anxiety, or depression. Despite these challenges, their developmental milestones—like walking and talking—were largely on track.
2. Mixed ASD with Developmental Delay (19%)
   These children showed developmental delays but had mixed levels of core autism traits. They were less likely to show psychiatric symptoms like anxiety or mood disorders.
3. Moderate Challenges (34%)
   This group showed less intense autism-related behaviors and achieved developmental milestones at typical ages. They also had a lower occurrence of additional psychiatric conditions.
4. Broadly Affected (10%)
   The most affected group had wide-ranging difficulties across development, behavior, and mental health, including delays and mood regulation issues. These classifications, though not comprehensive, represent the most clearly distinct clusters in this dataset. The subtypes were also validated in a second, independent group of autistic children.

Genetic Differences Reflect Clinical Profiles

Each subtype showed unique patterns of genetic variation. For example, the Broadly Affected group had the highest rate of damaging de novo mutations—those not inherited from parents. In contrast, the Mixed ASD group had more inherited rare variants. These differences suggest separate biological pathways leading to similar outward symptoms.

The study also revealed that the timing of gene activity varied between groups. In the Social and Behavioral Challenges subtype, mutations occurred in genes that become active after birth, possibly explaining why these children were diagnosed later and did not show developmental delays.

Toward Personalized Autism Care

Experts say the findings offer a starting point for more targeted diagnosis and intervention. “These are not just clinical labels,” says co-lead author Aviya Litman, “they are grounded in biology.” For families, knowing a child’s subtype could help guide expectations, support plans, and treatment choices.

While more work is needed—especially to include more diverse populations—the study provides a framework that could redefine autism care. “It’s a shift from trying to explain all of autism with one model,” says Natalie Sauerwald, co-lead author, “to recognizing multiple biological narratives.”

This research, part of a decade-long effort funded by the Simons Foundation and others, highlights the value of integrating genetics, psychology, and data science. As researchers apply this model to other complex conditions, it opens new possibilities for understanding—and treating—human diversity in health.

[Source]

The post Researchers Identify Four Autism Subtypes with Distinct Genetic Profiles appeared first on Medical Journal Daily.

Although rare, these disorders are serious. It’s estimated that around one in every 5,000 babies is affected by a mitochondrial condition, and for many families, the risk of passing it on is significant. Until recently, options for prevention were extremely limited.

That’s where mitochondrial replacement therapy (MRT) comes in. Sometimes referred to as three-parent IVF, this technique offers a way to stop these diseases from being inherited in the first place—by replacing the faulty mitochondria with healthy ones from a donor.

How It Works: Rebuilding an Egg Cell

The process starts with an egg from the mother that contains her nuclear DNA but also has mutated mitochondria. Doctors first remove the nuclear DNA, leaving behind the defective mitochondria. They then take a donor egg—which has healthy mitochondria—and remove its nucleus, keeping the healthy mitochondrial material intact.

Next, the mother’s nuclear DNA is inserted into the donor egg. The reconstructed egg now carries almost all of its genetic code from the intended parents and only a small amount from the donor. This egg is then fertilized with the father’s sperm, resulting in an embryo that has the nuclear DNA of the mother and father, and mitochondrial DNA from the donor.

In terms of genetics, the child will have over 99.9% of their DNA from their biological parents. The remaining fraction—less than 0.1%—comes from the mitochondrial donor, and it only affects cellular energy production, not personal traits or appearance.

Why It Matters: Stopping Disease Before It Starts

Unlike treatments that try to manage symptoms, this technique aims to prevent mitochondrial diseases entirely. For families with a history of these disorders, it’s a way to have a genetically related child without the fear of passing on a life-threatening condition.

The method has strict eligibility requirements. It’s only used when there’s a high risk of mitochondrial disease and when other reproductive technologies are unlikely to work. It’s not a tool for genetic enhancement or selection, but a targeted fix for a specific medical problem.

The UK’s Role and Global Outlook

In 2015, the UK became the first country to legalize mitochondrial replacement therapy under regulatory oversight. Clinics like the Newcastle Fertility Centre have since been allowed to offer the procedure under a license, making the UK the only country where MRT is permitted as part of regular medical care.

Although other countries, including the US and Australia, have shown interest in the technology, they have not yet approved it for clinical use. In the US, MRT is currently restricted to research settings.

Lingering Questions and Long-Term Monitoring

While the technique is promising, it is not without uncertainties. A tiny amount of the mother’s faulty mitochondria can sometimes be transferred along with the nucleus, though early results suggest this “carry-over” is minimal and unlikely to cause harm.

Still, long-term follow-up is essential. Scientists are monitoring the health of children born through MRT to better understand how these small amounts of mutant mitochondria behave over time and whether any risks could emerge later in life—or even in future generations.

[Source: 1,2]

The post How Three-Parent IVF Can Prevent Inherited Mitochondrial Diseases appeared first on Medical Journal Daily.

Match Your Workout to Your Personality

Not everyone enjoys the same kind of exercise, and this isn’t just about preference—it’s about personality. The UCL researchers used the Big Five personality model to explore how traits like extroversion or neuroticism influence workout enjoyment.

People who are more outgoing often enjoy fast-paced group activities like high-intensity interval training (HIIT). These types of workouts match their energy levels and provide the social interaction they enjoy.

On the other hand, individuals who tend to feel anxious or easily stressed may prefer exercising alone and in shorter sessions. They’re more likely to stick with routines that offer privacy, minimal monitoring, and quick bursts of activity instead of longer, drawn-out workouts.

Conscientious types, who are naturally disciplined and goal-oriented, show strong overall fitness. They might not need enjoyment to stay motivated, so consistency and routine may work better than variety.

The takeaway: You don’t need to force yourself into a routine that doesn’t feel right. Your own tendencies can guide you to a more sustainable fitness habit.

Enjoyment Leads to Consistency

In the study, 132 participants were split into two groups—one did an eight-week home workout plan, and the other kept their usual routine. The ones who exercised didn’t just get stronger and fitter—they also reported what they enjoyed.

The key finding? People who enjoyed their workouts were more likely to stick with them. Enjoyment wasn’t tied to one single exercise method. Instead, it varied by personality. If a session felt good, participants were more engaged. This supports a simple but powerful idea: when exercise feels like a chore, it’s hard to keep it going.

Try asking yourself after each workout: Did I enjoy that? Would I do it again? Let that answer shape your next session.

Exercise Lowers Stress—Especially If You’re Anxious

The research also measured stress before and after the program. At the start, both exercisers and non-exercisers felt the same. After eight weeks, those who worked out—especially participants with high neuroticism—showed a clear drop in stress.

This suggests that even people who are most likely to avoid exercise because of anxiety or overthinking may benefit the most from it. The key is to avoid pushing yourself into a workout style that causes discomfort or self-consciousness. A short, solo routine you can do at home may be enough to build fitness and improve mood.

It’s a reminder that fitness isn’t one-size-fits-all. A calm walk, a short circuit, or a quick ride on a bike may do more for your mental health than a gym session that feels forced.

The UCL study shows that understanding these traits can help you build a routine that works with your natural tendencies instead of against them. Try different styles, notice how they feel, and trust that enjoyment is a good sign you’re on the right track.

[Source]

The post Hate Exercise? Try This Personality-Based Approach That Actually Works appeared first on Medical Journal Daily.

The patient was scheduled for a biopsy and video-assisted thoracoscopic surgery (VATS) to remove suspicious lung nodules, likely linked to a sarcoma treated four years earlier. His condition suggested he would not need pain relief. But previous surgeries had revealed a complication: although he could not feel pain in the usual sense, his body still reacted strongly after surgery.

When No Pain Still Means Discomfort

During the operation, his vital signs remained completely stable. No changes in heart rate, blood pressure, or breathing were observed, even during incisions. This confirmed that his nervous system did not register pain in the expected way. Yet in the hours after surgery, the picture changed. He developed mild fever, high blood pressure, and rapid heartbeat — signs typically associated with pain or infection.

To manage these symptoms, the team used standard pain medications, including patient-controlled doses of oxycodone and later oral paracetamol and opioids. The symptoms eased, even though the patient insisted he felt no pain. Interestingly, he began to feel nauseous from the medication and eventually stopped the stronger drugs. Despite this, milder analgesics kept his symptoms in check.

Rethinking Pain Management in Special Cases

This case suggests that pain perception is not the only signal that matters after surgery. The body’s internal stress response — involving hormones, heart rate, and immune activity — can still be triggered even if the brain does not interpret pain normally. In this patient, those physiological responses were real and measurable, despite his insensitivity.

Painkillers, especially opioids, appear to have helped by calming that internal alarm system. It raises the question: should post-operative care rely only on what the patient reports, or should it also consider unseen responses? In this case, not treating these reactions might have led to complications or delayed recovery.

What the Medical Literature Says

A review of related case reports supports this mixed picture. In some patients with similar conditions, surgery was performed with little or no anaesthetic, and they recovered without issue. But others, like this patient, showed significant changes in blood pressure or heart rhythm in response to procedures. One large review found that even though pain was absent, the body sometimes still reacted with stress signals such as fever and heart rate changes.

It is also notable that different types of congenital pain insensitivity can have different effects on the autonomic nervous system. Some patients have difficulty regulating temperature or heart rate, while others do not. This variation makes it difficult to apply a one-size-fits-all approach to care.

What This Could Mean for Future Protocols

The case challenges the current trend of reducing opioid use in post-surgical care by showing that even patients who cannot feel pain may need them. It also suggests that clinicians should monitor not only pain scores but also vital signs and stress indicators, especially in rare neurological conditions.

Customizing care based on individual physiology — rather than relying solely on reported pain — could lead to better outcomes for patients with unusual conditions. As medical knowledge advances, understanding the full picture of how the body responds to surgery may help shape safer and more effective treatment plans.

[Source]

The post Do We Need Opioids Only to Relieve Pain? A Man Who Could Not Feel Pain Still Needed Opioids After Surgery appeared first on Medical Journal Daily.

The therapy, known as zimislecel, is made from lab-grown islet cells developed from pluripotent stem cells. These engineered cells are designed to replace the insulin-producing beta cells destroyed in people with type 1 diabetes. In the study, the cells were delivered into patients’ livers through the portal vein and began producing insulin naturally.

A Small but Promising Study

The trial, conducted by Vertex Pharmaceuticals, involved 14 participants. All had type 1 diabetes with no measurable C-peptide at baseline, indicating an absence of natural insulin production. Of the 12 individuals who received the complete zimislecel infusion, 10 no longer required insulin a year later.

Each participant showed signs of functioning islet cells and avoided any serious hypoglycemic incidents during the last nine months of follow-up.

The trial results, presented at the 2025 American Diabetes Association conference and published in The New England Journal of Medicine, point to zimislecel as a possible treatment route for patients with difficult-to-manage or advanced type 1 diabetes.

Restoring Natural Insulin Production

Participants in the trial had previously lived with hypoglycemic unawareness, a complication where the body no longer warns of dangerously low blood sugar levels. This can result in sudden fainting, seizures, or even death. Following treatment with a full dose of zimislecel, none of the 12 participants experienced additional episodes of dangerously low blood sugar.

The infusion triggered insulin production within weeks. Patients began reducing their insulin requirements around the three-month mark, with most stopping entirely by month six. All participants spent more than 70 percent of their time in the recommended blood glucose range between 70 and 180 mg/dL.

Amanda Smith described the experience as a return to normalcy. She joined the study after years of managing her blood sugar around the clock. The result, she said, has been “a whole new life,” though she remains on immunosuppressive medication to preserve the function of the transplanted cells.

Managing the Risks of Immune Suppression

To prevent the body from rejecting the implanted cells, all participants were placed on immunosuppressive drugs. While these medications were chosen to avoid corticosteroids, they still carry risks.

Three participants developed neutropenia, a condition that weakens the immune system, and two died during the study’s follow-up period. One death was linked to fungal meningitis, and the other to worsening dementia. Both patients had underlying medical conditions before entering the trial.

Researchers acknowledged these risks and emphasized the importance of long-term monitoring. “We’re still learning what this means over the course of many years,” said Dr. Trevor Reichman, pancreas and islet transplant program director at University Health Network in Toronto and lead author of the study.

Built on Decades of Research

Zimislecel is the result of over two decades of work, beginning with a Harvard lab led by Dr. Doug Melton. Motivated by his children’s diagnoses with type 1 diabetes, Dr. Melton focused his career on transforming stem cells into functioning islet cells. After finding a reliable method, the research was taken forward by Vertex Pharmaceuticals for clinical development.

The trial was limited to patients with severe diabetes who could not manage their condition effectively with current therapies. Enrollment was selective, and some eligible patients declined participation after learning they would need immunosuppressive drugs for life.

A New Option for a High-Risk Group

Dr. Irl Hirsch, a diabetes expert from the University of Washington who was not affiliated with the research, observed that the therapy may serve a critical role for patients at high risk of sudden and severe glucose drops. He added that for patients with well-managed type 1 diabetes, the trade-offs may not be worth the risk until safer long-term data become available.

Zimislecel is not yet approved for public use, and pricing has not been disclosed. Vertex plans to continue testing zimislecel in future studies and aims to submit its findings to the U.S. Food and Drug Administration for review.

For patients like Amanda Smith, the therapy represents a shift in what diabetes care could look like. Though not a cure, zimislecel shows that it may be possible to restore the body’s own insulin production with a single intervention—at least for those who need it most.

[Source]

The post Type 1 Diabetes Patients Off Insulin After a Single Dose of Experimental Manufactured Stem Cells appeared first on Medical Journal Daily.

The Hidden Risks of Dirty Humidifiers

Several studies have identified the growth of Legionella pneumophila, Pseudomonas aeruginosa, and fungal species like Aspergillus in improperly cleaned humidifiers. These pathogens can be aerosolized and inhaled, especially through ultrasonic or cool-mist humidifiers, which do not boil water before dispersal.

Studies have shown that neglected humidifiers can harbor bacteria and mold. Organisms such as Legionella pneumophila, Pseudomonas aeruginosa, and various fungal species have been found in humidifier tanks and internal components.

These pathogens can be aerosolized and inhaled, especially through ultrasonic or cool-mist humidifiers, which do not boil water before dispersal.

When the device is in use, these microbes can be released into the air along with the water vapor. Inhaling contaminated mist has been linked to a range of respiratory problems, including asthma flare-ups, lung inflammation, and hypersensitivity pneumonitis, a condition sometimes referred to as humidifier lung.

In December 2008, a large Legionella outbreak in a hospital neonatal unit was traced back to contaminated humidifiers, emphasizing the importance of disinfection even in controlled clinical environments.

CDC and EPA Recommendations on Humidifier Hygiene

According to the Centers for Disease Control and Prevention, one of the most important ways to prevent microbial growth in a humidifier is to avoid letting water sit in the tank for extended periods. The CDC recommends that users remove any remaining water from the humidifier each day, and allow the tank to dry completely.

The Environmental Protection Agency offers similar guidance for home humidifiers, emphasizing the importance of using distilled water rather than tap water, as minerals in untreated water can support bacterial growth.

Step-by-Step: How to Clean a Humidifier Safely

Daily Maintenance:

1. Unplug the humidifier and empty the tank.
2. Rinse all components with clean water.
3. Dry thoroughly.
4. Refill with fresh distilled water.

Weekly Deep Clean:

1. Disassemble the unit.
2. Prepare a cleaning solution by mixing one tablespoon of three percent hydrogen peroxide or white vinegar with each cup of water, then pour it into the tank.
3. Allow this solution to sit for about 20 to 30 minutes to loosen any buildup and gently scrub away any visible residue.
4. Once cleaned, rinse all parts thoroughly with clean water and let them dry completely before putting the unit back together.

Monthly Disinfection (or as recommended):

1. Use diluted bleach: 1 teaspoon per gallon of water.
2. Let it soak for 20 minutes, rinse several times with clean water.

Avoid using essential oils or additives unless the humidifier is designed for them, as they can promote residue buildup and bacterial growth.

Why This Matters in Healthcare and At Home

Indoor air quality plays an increasingly important role in public health, particularly as people spend more time indoors. Humidifiers, if improperly cleaned, can release fine droplets containing microbes and minerals into the air.

This adds to the overall particulate matter in enclosed spaces and can compromise air quality. According to environmental health studies, poor indoor air quality has been associated with increased rates of respiratory illnesses, allergic reactions, and chronic lung conditions.

Respiratory infections from contaminated humidifiers may go underdiagnosed or misattributed to other causes like seasonal allergies or viral infections. In clinical environments, especially where patients are immunocompromised, strict adherence to maintenance protocols can significantly reduce the risk of airborne transmission of pathogens.
[Source]

The post How to Clean Your Humidifier to Prevent Airborne Infections appeared first on Medical Journal Daily.